In this regard, GLP-1RAs can provide the protection against VSMC senescence via increasing the nuclear factor erythroid 2-related factor 2 (Nrf2) activity [122]
Doing so allows cells to take up glucose and inhibits glucagon secretion, which prevents more glucose from releasing into the bloodstream
FFAs induce oxidative stress by generating ROS, which promote lipid peroxidation and activate cell death pathways, thereby exacerbating the vicious cycle between mitochondrial failure and ER stress (Rabbani and Thornalley, 2023, 2024)
The future directions and challenges of new small-molecule GLP-1R agonists, such as danuglipron, are multifaceted
Some people notice appetite changes first, while others see changes in weight or waist measurements later